A licensed provider in your state then reviews the information and recommends a course of action
Additional best practices include: never reusing needles, as this increases infection risk and causes needle dulling that makes injections more painful
Current injectable GLP-1 medications have demonstrated weight reductions of 1522% in landmark trials, while patch formulations remain largely experimental
Continuous GLP-1RA use for three years was associated with the greatest reduction in MACE risk compared with sulfonylureas, whereas interruptions and discontinuations were associated with a progressive attenuation of this protective effect, with risk estimates in some scenarios approaching those of the comparator group
Psyllium husk supplements can help regulate bowel movements when added gradually
Most patients who stop GLP-1 treatment regain a significant portion of the weight they lost, which is why discontinuation is generally not recommended unless side effects or other clinical concerns warrant it